Respiratory Failure. Respiratory failure, unspecified
Conditions
Interventions
Intervention 1: Control group: Patients in this group receive 20 grams of enteral high protein formula (Karen Pharma & Food Supplement, Co., Tehran, Iran) once a day for a minimum of 5 days and a maxi
Sponsors
National Nutrition & Food Technology Research Institute
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with acute respiratory failure Completion of informed consent form by the patient or legal guardian Feeding by enteral nutrition 18-65 years old Body Mass Index less than 35 kg/m2
Exclusion criteria
Exclusion criteria: No metastatic cancer or end stage disease Lack of intolerance to milk (lactose) Don't participate in other clinical trial studies at the same time as the present study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of nosocomial infection. Timepoint: The incidence of nosocomial infection is assessed up to 3 days after discharge from the hospital. Method of measurement: The incidence of nosocomial infection is based on the results of laboratory tests and medical records. | — |
Secondary
| Measure | Time frame |
|---|---|
| The Mean concentration of serum CD markers (CD4, CD8). Timepoint: The CD markers (CD4, CD8) variable are measured at the beginning and end of the intervention. Method of measurement: Evaluation of CD marker variables (CD4, CD8) are performed using ELISA method and related kits.;The Mean concentration of serum Insulin-like Growth Factor1. Timepoint: The Insulin-like Growth Factor1 variable is measured at the beginning and end of the intervention. Method of measurement: Evaluation of Insulin-like Growth Factor1 is performed using ELISA method and related kits.;Duration of hospitalization in the hospital, duration of hospitalization in the intensive care unit. Timepoint: The evaluation of these variables is from the beginning of the intervention to the time of hospitalization of the patient in the hospital and intensive care unit. Method of measurement: The evaluation of these variables is based on the information recorded in the patients' hospital records.;Patient mortality rate in hospital and intensive care unit. Timepoint: The evaluation of these variables is from the beginning of the intervention to the time of possible death of the patient in the hospital and intensive care unit. Method of measurement: The evaluation of these variables is based on the information recorded in the patients' hospital records.;Gastrointestinal complications (diarrhea, constipation, nausea, abdominal distension). Timepoint: Evaluation of these variables is from the beginning of the intervention to the end of the intervention. Method of measurement: Based on reports recorded in the patient's file. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Rouhelhami
Shahid Beheshti University of Medical Sciences
Outcome results
None listed